Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AUAssessing Ultegra) multicenter study - Steinhubl, SR; Talley, JD; Braden, GA (Circulation, 2001)
et al.